XML 31 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Employee Benefits
12 Months Ended
Dec. 31, 2021
Employee Benefits [Abstract]  
Employee Benefits 9.     EMPLOYEE BENEFITS 401(K) AND BONUS AND INCENTIVE PLANS The Company maintains a 401(k) and bonus and incentive plans covering executives, managers, and employees. Excluding the 401(k), at the CEO’s discretion, funding of these plans is primarily dependent upon reaching predetermined levels of combined ratio, reduction in operating expenses, growth in direct written premium, and overall renewal retention ratios. Bonuses are earned as the Company generates earnings in excess of this required return. While some management incentive plans may be affected somewhat by other performance factors, the larger influence of corporate performance ensures that the interests of the executives, managers, and employees corresponds with those of the stakeholders. The 401(k) plan offers a matching percentage up to 4% of eligible compensation, as well as a profit sharing percentage of each employee’s compensation. Participants are 100% vested in the matching percentage and vest at a rate of 25% per year for the profit sharing distribution. The total contribution to the 401(k) profit sharing plan was $272,527 and $266,024 for 2021 and 2020, respectively. Additionally, bonuses may be awarded to executives, managers, and associates through company incentive plans, provided certain financial or operational goals are met. DEFERRED COMPENSATION In November 2012, the Company entered into a deferred compensation agreement with an executive of the Company. The agreement requires the Company to make payments to the executive beginning at retirement (age 62). In the event of separation of service without cause prior to age 62, benefits under this agreement vest 25% in November 2017, 50% in November 2022, 75% in November 2027, and 100% on January 1, 2032. In the event of death prior to retirement, benefits become fully vested and are payable to the executive’s beneficiaries. Using a discount rate of 3.6%, the fully vested obligation under the agreement would total approximately $1,689,467 on January 1, 2032. As of December 31, 2021 and 2020, the accrued liability related to this agreement totaled $529,117 and $470,446, respectively. The Company recognized $58,671 and $122,459 of expense in 2021 and 2020, respectively. ESOPIn connection with our conversion and public offering, we established an ESOP. The ESOP borrowed from the Company to purchase 350,000 shares in the offering. The issuance of the shares to the ESOP resulted in a contra account established in the equity section of the balance sheet for the unallocated shares at an amount equal to their $10.00 per share purchase price.The Company may make discretionary contributions to the ESOP and pay dividends on unallocated shares to the ESOP. The ESOP uses funds it receives to repay the loan. When loan payments are made, ESOP shares are allocated to participants based on relative compensation and expense is recorded. The Company contributed $293,862 and $294,734 to the ESOP during the twelve months ended December 31, 2021 and 2020. A compensation expense charge is booked monthly during each year for the shares committed to be allocated to participants that year, determined with reference to the fair market value of our stock at the time the commitment to allocate the shares is accrued and recognized. For the year ended December 31, 2021, we recognized compensation expense of $369,773 related to 23,437 shares of our common stock that were committed to be released to participants’ accounts for the year ended December 31, 2021. Of the 23,437 shares committed to be released, 1,926 shares were committed on December 31, 2021 and had no impact on the weighted average common shares outstanding for the year ended December 31, 2021. For the year ended December 31, 2020, we recognized compensation expense of $283,222 related to 23,437 shares of our common stock that were committed to be released to participants’ accounts for the year ended December 31, 2020. Of the 23,437 shares committed to be released, 1,985 shares were committed on December 31, 2020 and had no impact on the weighted average common shares outstanding for the year ended December 31, 2020. The fair value of the unearned ESOP shares as of December 31, 2021 and December 31, 2020 was $3,925,770 and $3,686,702, respectively. RESTRICTED STOCK UNITS RSUs were granted for the first time in February 2018 with additional RSUs being granted in March 2019, April 2020, and April 2021. RSUs have a grant date value equal to the closing price of the Company’s stock on the dates the shares are granted. The RSUs vest 1/3 over three years from the date of grant.  As of December 31, 2021, 11,700, 13,071, 18,040 and 15,000 RSUs have been granted at a fair market value of $15.10, $13.70, $11.03 and $14.78 per share, respectively. As of December 31, 2020, 11,700, 13,071 and 18,040 RSUs have been granted at a fair market value of $15.10, $13.70 and $11.03 per share, respectively. We recognized $186,897 and $171,755 of expense on these units in the twelve months ended December 31, 2021 and 2020, respectively. Total unrecognized compensation expense relating to outstanding and unvested RSUs was $254,837 and $269,359 as of December 31, 2021, respectively, which is recognized over the remainder of the three year vesting periods.